No Data
No Data
Weitai Medical-B (02235) spent about HK$116,600 to buy back 28,200 shares on March 28
Weitai Medical-B (02235) announced that it will spend about HK$116,600 to return it on March 28, 2024...
Weitai Medical-B (02235.HK)'s revenue in 2023 increased by 45.9%. Revenue and gross margin are expected to continue to grow in 2024
Gelonghui, March 27 | Weitai Medical-B (02235.HK) announced that for the year ended December 31, 2023, the company achieved operating income of RMB 253.2 million, an increase of 45.9% over RMB 173.6 million for the year ended December 31, 2022, mainly due to the rapid growth of AideX's continuous glucose monitoring system, the steady growth of the Equil encapsulated insulin pump system, and the rapid growth of blood sugar monitoring systems. The above growth has benefited from the company's overseas customers, domestic professional markets and e-commerce Further expansion of channels. Duke
Weitai Medical-B (02235): Shi Yonghui was appointed as Joint Company Secretary
According to the Zhitong Finance App, Weitai Medical-B (02235) announced that Shi Yonghui has been appointed as the company's joint company secretary for a period of 3 years from March 27, 2024. Zhu Bimin, the sole company secretary of Dr. Shi, was appointed to continue as the other joint company secretary.
MICROTECH MED-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Weitai Medical-B (02235.HK) plans to hold a board meeting on March 27 to consider and approve the annual results
Gelonghui March 15 | Weitai Medical-B (02235.HK) announced that a board meeting will be held on March 27, 2024 (Wednesday), which includes reviewing and approving the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and considering a proposal to pay a final dividend (if any).
MICROTECH MED-B: NOTICE OF BOARD MEETING
No Data